Program
* The following session are all schedule in Japan Standard Time (JST).
- Session 1
- The GA2LEN UCARE Network - ongoing/new projects
Day 1 : December 9 6:15pm-8:00pm
- Session 2
- Introduction of new UCARE center
Day 1 : December 9 8:15pm-9:00pm
- Session 3
- A new frame of the pathogenesis of urticaria
Day 1 : December 10 8:00am-9:20am
- New roles of IgE and its receptors in the pathogenesis of urticaria
- Wheals with systemic symptoms
- Urticaria and COVID-19
- Roles of non-mast cells in the pathogenesis of urticaria
- Session 4
- Advances in treatments of urticaria
Day 2 : December 10 9:40am-10:40am
- Mast cell-targeted treatments
- Non-mast cell targeted treatments
- New treatments for CIndU
- Session 5
- 【Recurrent Angioedema】collaborated with the ACARE NETWORK
Day 2 : December 10 11:00am-11:40am
- Bradykinin mediated angioedema
- Non-bradykinin mediated angioedema
- Session 6
- Pediatric urticaria
Day 2 : December 10 3:00pm-3:40pm
- Chronic urticaria in children:
- Hereditary angioedema in children
- Session 7
- Case discussion
Day 3 : December 11 9:30am-10:30am
Case 1 | CSU exacerbated with omalizumab |
---|---|
Case 2 | Food-independent exercise-induced anaphylaxis presenting cholinergic urticaria-like eruptions |
Case 3 | Symptomatic dermographism with dyspnea treated with Alprazolam |
- Session 8
- 【Workshops】the CHARITE TEAM FOR THIS
Day 3 : December 11 11:00am-12:15pm
〈Room 1_ PROs〉Sponsored by Novartis
Introducing PROMs(Patient-reported outcome measures)(ex. UCT, ACT)
〈Room 2_ CIndU〉
- Temp test (and ice cube test): Heat urticaria, Cold urticaria
- Fric test: Symptomatic dermographism
- Photo testing: Solar urticaria
- Water provocation test: Aquagenic urticaria
- Session 9
- Urticaria Related Syndrome
Day 3 : December 11 2:15pm-3:30pm
- Urticaria and mast cells
- Mast cell activation syndrome (MCAS)
- Mathematical equation of multifarious eruptions in urticaria
Oral session
Day 2 : December 10 4:10pm-5:40pm / Day 2:December 10 6:00pm-7:30pm
Poster session
※VOTE FOR POSTER
Deadline:December 11 7:00am(JST)
Ondemand (December 9 - January 31)
Sponsored session
- Luncheon Seminar 1
- Review and perspective of allergic skin diseases associated with sweating
- Omalizumab Treatment in Chronic Spontaneous Urticaria: Real-world Evidences
Day 2 : December 10 12:00pm-1:00pm
- Luncheon Seminar 2
- To improve patient’s QOLwith careful attention and new treatment
- How to leverage our findings to improve HAE patients lives? - Based on studies from Japan
Day 3 : December 11 12:45pm-1:45pm
- Sponsored Symposium
- Beyond Mast Cells:
Emerging Theories in the Pathophysiology of Chronic Urticaria
Day 2 : December 10 1:50pm-2:40pm